Concepedia
Statistics
Publications
24
Citations
2.1K
H-Index
20
Active since
1982
Affiliations
MRC Toxicology Unit(Current)
Culham Science Centre
University of London
UCB Pharma (United Kingdom)
Oxford Lasers (United Kingdom)
Colin Stubberfield is an author at MRC Toxicology Unit specializing in life sciences, pharmacology, and biochemistry.
Publications per year
1982–2013
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
Xiaoxiao Cheng, Václav Veverka, Anand Radhakrishnan et al. · Journal of Biological Chemistry · 2013 · 332 citations · Full text
Life Sciences, Immunology, Molecular Biology +16
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.
David W. Rusnak, Karen Affleck, Stuart Cockerill et al. · PubMed · 2001 · 297 citations
Medicine, Oncology, Pharmacology +15
Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family Member
Edward A. McKenzie, Kerry Tyson, Alasdair C. Stamps et al. · Biochemical and Biophysical Research Communications · 2000 · 192 citations
Life Sciences, Biology, Molecular Biology +5
Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1)
Michael G. Orchard, Judi C Neuss, Carl M.S Galley et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 125 citations · Full text
Life Sciences, Biochemistry, Microbiology +15
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
John Porter, Andrew Payne, Ben de Candole et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 123 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
1–5 of 24